Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

Growth requires capital. As a small-business owner, you’ve likely felt that firsthand. Although personal savings can ...

Fiscal 2025 Results Consistent with Preliminary Unaudited Ranges Disclosed November 25, 2025BNC First Day Program Revenue Increases 25% in 2025; ...

Detailed price information for Vision Lithium Inc (VLI-X) from The Globe and Mail including charting and trades.

Discover how annual budgets project income and expenses over a year, aiding in financial planning for individuals, corporations, and governments. Learn about balanced budgets.